hydrogen has been researched along with Brain Diseases in 20 studies
Hydrogen: The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas.
dihydrogen : An elemental molecule consisting of two hydrogens joined by a single bond.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
Excerpt | Relevance | Reference |
---|---|---|
" First, no dose-response effect is observed." | 2.48 | Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. ( Ichihara, M; Ito, M; Ohno, K, 2012) |
"Four grades of demyelination and three grades of cerebral atrophy were distinguished by magnetic resonance imaging criteria." | 1.28 | 1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. ( den Hollander, JA; Luyten, PR; Nauta, JJ; Valk, J; van der Grond, J; van der Knaap, MS, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.00) | 18.7374 |
1990's | 12 (60.00) | 18.2507 |
2000's | 2 (10.00) | 29.6817 |
2010's | 3 (15.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iketani, M | 1 |
Ohsawa, I | 1 |
Mandal, PK | 1 |
Akolkar, H | 1 |
Ohno, K | 1 |
Ito, M | 2 |
Ichihara, M | 1 |
Sijens, PE | 1 |
Boon, M | 1 |
Meiners, LC | 1 |
Brouwer, OF | 1 |
Oudkerk, M | 1 |
Constans, JM | 1 |
Meyerhoff, DJ | 1 |
Gerson, J | 1 |
MacKay, S | 1 |
Norman, D | 1 |
Fein, G | 1 |
Weiner, MW | 3 |
Chang, L | 1 |
Miller, BL | 1 |
McBride, D | 1 |
Cornford, M | 1 |
Oropilla, G | 1 |
Buchthal, S | 1 |
Chiang, F | 1 |
Aronow, H | 1 |
Beck, CK | 1 |
Ernst, T | 1 |
Usenius, JP | 1 |
Vainio, P | 1 |
Puranen, M | 1 |
Soimakallio, S | 1 |
Kauppinen, R | 1 |
Gadian, DG | 1 |
Shaw, D | 1 |
Moonen, CT | 1 |
van Zijl, P | 1 |
Lorek, AK | 1 |
Penrice, JM | 1 |
Cady, EB | 1 |
Leonard, JV | 1 |
Wyatt, JS | 1 |
Iles, RA | 1 |
Burns, SP | 1 |
Reynolds, EO | 1 |
Jackson, EF | 1 |
Meyers, CA | 1 |
Träber, F | 1 |
Block, W | 1 |
Lamerichs, R | 1 |
Keller, E | 1 |
Schild, HH | 1 |
Burtscher, IM | 1 |
Ståhlberg, F | 1 |
Holtås, S | 1 |
Schuff, N | 1 |
Ezekiel, F | 1 |
Gamst, AC | 1 |
Amend, DL | 1 |
Capizzano, AA | 1 |
Maudsley, AA | 1 |
Orosz, E | 1 |
Deák, G | 1 |
Benoist, G | 1 |
van der Knaap, MS | 1 |
van der Grond, J | 1 |
Luyten, PR | 1 |
den Hollander, JA | 1 |
Nauta, JJ | 1 |
Valk, J | 1 |
Naritomi, H | 1 |
Sasaki, M | 1 |
Sappey-Marinier, D | 1 |
Jung, WI | 1 |
Grodd, W | 1 |
Lutz, O | 1 |
Petersen, D | 1 |
Hubesch, B | 1 |
Marinier, DS | 1 |
Hetherington, HP | 1 |
Twieg, DB | 1 |
Posin, JP | 1 |
Arakawa, M | 1 |
Crooks, LE | 1 |
Feinberg, DA | 1 |
Hoenninger, JC | 1 |
Watts, JC | 1 |
Mills, CM | 1 |
Kaufman, L | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT02830854] | Phase 3 | 13 participants (Actual) | Interventional | 2016-07-31 | Completed | ||
[NCT01759498] | Phase 2 | 36 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for hydrogen and Brain Diseases
Article | Year |
---|---|
Molecular Hydrogen as a Neuroprotective Agent.
Topics: Animals; Brain Diseases; Humans; Hydrogen; Neuroprotective Agents; Oxidative Stress | 2017 |
Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases.
Topics: Animals; Brain Diseases; Disease Models, Animal; Gases; Humans; Hydrogen; Metabolic Diseases; Neurod | 2012 |
Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases.
Topics: Animals; Brain Diseases; Disease Models, Animal; Gases; Humans; Hydrogen; Metabolic Diseases; Neurod | 2012 |
Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases.
Topics: Animals; Brain Diseases; Disease Models, Animal; Gases; Humans; Hydrogen; Metabolic Diseases; Neurod | 2012 |
Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases.
Topics: Animals; Brain Diseases; Disease Models, Animal; Gases; Humans; Hydrogen; Metabolic Diseases; Neurod | 2012 |
[Magnetic spectroscopy--a new method for studying the brain].
Topics: Brain; Brain Diseases; Brain Neoplasms; Epilepsies, Partial; Humans; Hydrogen; Magnetic Resonance Sp | 1993 |
Introduction to hippocampal spectroscopy.
Topics: Aspartic Acid; Brain Diseases; Choline; Creatine; Hippocampus; Humans; Hydrogen; Image Enhancement; | 1997 |
[Recent studies of cerebral metabolism by nuclear magnetic resonance spectroscopy].
Topics: Animals; Brain; Brain Diseases; Carbon Isotopes; Fluorine; Humans; Hydrogen; Magnetic Resonance Spec | 1990 |
15 other studies available for hydrogen and Brain Diseases
Article | Year |
---|---|
A new experimental approach and signal processing scheme for the detection and quantitation of ³¹P brain neurochemicals from in vivo MRS studies using dual tuned (¹H/³¹P) head coil.
Topics: Brain; Brain Chemistry; Brain Diseases; Ethanolamines; Humans; Hydrogen; Magnetic Resonance Spectros | 2011 |
1H chemical shift imaging, MRI, and diffusion-weighted imaging in vanishing white matter disease.
Topics: Ataxia; Brain Diseases; Diffusion Magnetic Resonance Imaging; Humans; Hydrogen; Infant; Magnetic Res | 2005 |
H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Diseases; Brain Ischemia; Case-Control Studies; | 1995 |
Brain lesions in patients with AIDS: H-1 MR spectroscopy.
Topics: Abscess; Adult; AIDS Dementia Complex; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Crea | 1995 |
Advances in proton magnetic resonance spectroscopy of the brain. A report on a workshop held in Oxford, England December 16-18, 1992.
Topics: Aspartic Acid; Biomarkers; Brain; Brain Chemistry; Brain Diseases; England; Humans; Hydrogen; Magnet | 1993 |
Cerebral energy metabolism in isovaleric acidaemia.
Topics: Brain; Brain Diseases; Energy Metabolism; Female; Humans; Hydrogen; Infant; Infant, Newborn; Isovale | 1996 |
[Shortening of the measurement time by 1H-MR turbo spectroscopic imaging of the brain].
Topics: Adult; Artifacts; Brain; Brain Diseases; Female; Fourier Analysis; Humans; Hydrogen; Image Processin | 1997 |
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neo | 1997 |
Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging.
Topics: Aged; Aged, 80 and over; Aging; Analysis of Variance; Aspartic Acid; Brain; Brain Diseases; Choline; | 2001 |
Effect of ethyl apovincaminate on the cerebral circulation. Serial angiography and regional cerebral circulation studies in neurosurgical patients.
Topics: Brain Diseases; Cerebral Angiography; Cerebrovascular Circulation; Humans; Hydrogen; Indicator Dilut | 1976 |
1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders.
Topics: Adult; Aspartic Acid; Atrophy; Brain; Brain Diseases; Child; Creatine; Demyelinating Diseases; Human | 1992 |
High-resolution NMR spectroscopy of cerebral white matter in multiple sclerosis.
Topics: Body Water; Brain; Brain Chemistry; Brain Diseases; Cholesterol; Female; Humans; Hydrogen; Magnetic | 1990 |
Localized 1H in vivo NMR spectroscopy of small-volume elements in human brain at 1.5 T.
Topics: Body Water; Brain; Brain Diseases; Humans; Hydrogen; Image Enhancement; Magnetic Resonance Spectrosc | 1990 |
Clinical MRS studies of the brain.
Topics: Brain; Brain Diseases; Brain Neoplasms; Epilepsy, Temporal Lobe; Humans; Hydrogen; Hydrogen-Ion Conc | 1989 |
Hydrogen MR imaging of the head at 0.35 T and 0.7 T: effects of magnetic field strength.
Topics: Brain; Brain Diseases; Humans; Hydrogen; Magnetic Resonance Spectroscopy; Magnetics | 1985 |